Abstract
Disease activity of acromegaly can be measured in many ways. Growth hormone (GH) and insulin-like growth factor 1 (IGF1) concentrations are the main biochemical markers used to measure the response to treatment. Both GH and IGF1 have been associated with prognosis, in particular mortality. In this review, we discuss the available parameters to assess disease activity in acromegaly.
© 2012 Blackwell Publishing Ltd.
MeSH terms
-
Acromegaly / diagnosis
-
Acromegaly / drug therapy
-
Acromegaly / metabolism*
-
Biomarkers / metabolism*
-
Human Growth Hormone / analogs & derivatives
-
Human Growth Hormone / metabolism*
-
Human Growth Hormone / therapeutic use
-
Humans
-
Insulin-Like Growth Factor I / metabolism*
-
Outcome Assessment, Health Care / methods
-
Prognosis
-
Quality of Life
-
Surveys and Questionnaires
Substances
-
Biomarkers
-
Human Growth Hormone
-
Insulin-Like Growth Factor I
-
pegvisomant